Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2008-002498-11Phase 2Completed
Phase 2, randomised, open-label trial of nicotine in nicotine dependence (2 arms), sponsored by McNeil Laboratories. Primary endpoint: mean hourly and daily number of spray doses used during weeks 1, 2, and 3. Started Jun 2008; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2008-002498-11.